(Q44424388)

2 December 2017

title

Interaction between ketoconazole and almotriptan in healthy volunteers (English)

1 reference

2 December 2017

Joseph C Fleishaker

1

1 reference

2 December 2017

Beth D Herman

series ordinal

2

1 reference

2 December 2017

Barbara J Carel

series ordinal

3

1 reference

2 December 2017

Nkechi E Azie

series ordinal

4

1 reference

2 December 2017

publication date

1 April 2003

1 reference

The Journal of Clinical Pharmacology

2 December 2017

published in

1 reference

2 December 2017

volume

43

1 reference

2 December 2017

issue

4

1 reference

2 December 2017

page(s)

423-427

1 reference

How does almotriptan compare with other triptans? A review of data from placebo-controlled clinical trials

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252242

Hemodynamic and electrocardiographic effects of almotriptan in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252242

The use of other drugs to allow a lower dosage of cyclosporin to be used. Therapeutic and pharmacoeconomic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252242

Effect of MAO-A inhibition on the pharmacokinetics of almotriptan, an antimigraine agent in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252242

Almotriptan: a review of its use in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252242

Pharmacokinetic interaction between verapamil and almotriptan in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270003252242

21 January 2018

Identifiers

DOI

10.1177/0091270003252242

1 reference

2 December 2017

1 reference